Navigation Links
Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance

AMSTERDAM, June 29 /PRNewswire/ --

- Allows Institutions to Optimize Strategic Funding, Hiring and Collaboration Decisions

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today announced the launch of SciVal Spotlight, a customized web-based tool that offers institutions a unique multidisciplinary perspective of research performance to evaluate, establish and execute more informed research strategies.

SciVal Spotlight uses an innovative visualization technique to produce customized maps that provide graphical views of an institution's performance over time and across scientific fields, focusing on specific topical areas. By pinpointing a university's topical strengths and identifying leading researchers and institutions in each area, the tool is designed to help academic decision-makers optimize funding allocations and enhance hiring and collaboration decisions.

Quantifying the overall size of each topical area, the tool allows institutions to understand the significance of their article and market shares and how they rank compared to competitors in those areas. It also assesses article and market growth or decline over the last five years, offering an average rate for each using a two year sliding scale. Additionally, it determines if an institution's work is building upon the most recent discoveries; providing a "state of the art quotient" by analyzing how recent the citations are within its published output.

"We recognized a need to change the way research is currently being measured, and designed the tool to provide a more holistic and integrated view of performance," explained Jay Katzen, Managing Director, Academic and Government Products. "By capturing the unique research fingerprint of each institution, we can help academic executives better understand their core strengths and potential weaknesses so they can develop and implement successful long-term research strategies."

Moving beyond the traditional method of measuring research output by journal count, SciVal Spotlight is based on a more detailed model of the current structure of science. The model, covering virtually all of the research being published across the globe, was developed using co-citation analysis of a comprehensive database that includes 6.1 million separate papers published between 2004 and 2008, and another two million of the highly-cited references from these papers.

Leveraging this new model of science, SciVal Spotlight identifies and focuses on the inter-related work being done within an institution which represents the unique topical areas or "distinctive competencies" in which it is a leader. It also offers an opportunity to better understand which institutions are true competitors by revealing those that compete within the same research competencies.

"The square peg, round hole nature of evaluating research performance based on the broad classifications of journals no longer captures the reality of today's multidisciplinary scientific landscape," explains Kevin Boyack, a senior development advisor for Elsevier. "SciVal Spotlight provides academic decision-makers with a more accurate picture of research productivity. It allows them to evaluate performance based on the breakthroughs they are trying to achieve, rather than the classification of the journals in which their researchers are publishing articles."

About the Elsevier SciVal Suite

The SciVal suite of services delivers intelligence solutions to help the academic and government research communities evaluate, establish and execute their research strategies more effectively. The suite currently includes SciVal Spotlight and SciVal Funding.

With traditional research performance measurement options unable to capture the reality of today's multidisciplinary scientific landscape, the SciVal Spotlight tool is designed to provide research managers with a more accurate picture of any institution's unique research strengths and opportunities.

SciVal Funding is an online funding intelligence solution that enables researchers and research administrators to better compete for research funding. The tool provides access to over 5,000 funding sources and includes targeted recommendations based on pre-populated research profiles as well as an extensive history of awarded grants.

For more information on the SciVal Suite, please visit

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (, MD Consult (, Scopus (, bibliographic databases, and online reference works.

Elsevier ( is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


    Jessica Disch
    Amanda Sham
    Phone: +1-212-752-8338

SOURCE Elsevier B V
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Elsevier Announces 2008 Journal Impact Factor Highlights
2. /C O R R E C T I O N -- Elsevier/
3. Elsevier Honored as "The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences" by the Special Libraries Association
4. Elsevier launches online version of the Chinese Journal of Natural Medicines
5. Elsevier to Create New Guidelines for Pharmaceutical Article Reprint, Compilation and Custom Publications
6. Elseviers PharmaPendium(TM) Introduces the FDA Classic Collection
7. Elseviers PharmaPendium introduces the FDA Classic Collection
8. Elsevier Appoints Chris Dillon as Managing Director, Clinical Decision Support
9. Elsevier launches Epidemics -- the journal on infectious disease dynamics
10. Milestone tumor virus publication by Elsevier journal Virology
11. Elsevier Acquires Professional Development Software, Inc., Provider of Software for Nurses Online Learning Education
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... The Foundation ... cancer education and prevention—is joining forces with the award-winning creator and writer of ... on December 7, 2015 at the Union League of Philadelphia. , The ...
(Date:11/30/2015)... ... , ... The American Society for Clinical Pathology (ASCP) announced today that it ... Nov. 30, ASCP shared its “Give a minute. Get tested. Find a cure.” icon ... of getting tested for HIV. , ASCP has asked members to replace their Facebook, ...
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag ... exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage in ... immediately. , “We are pleased to announce our expanded distribution agreement with ...
(Date:11/30/2015)... ... November 30, 2015 , ... According ... Hansen, Ph.D., a senior scientist at Consumer Reports as supporting a “A Call ... child’s exposure limits. , The original Nov 2015 CR story titled, “Does Cell-Phone ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... last 15 years, announced today that Michigan-based Family Health Center (FHC) has selected ... over 45 years, FHC was awarded the largest Affordable Care Act grant for ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015 Next week, December 2-3, ... Things (DoT ) co-located events covering the latest in ... of Things, will draw more than 3,000 design industry ... Convention Center. The events, combined show floor will host ... --> --> BIOMEDevice ...
(Date:11/30/2015)... global cell culture market is expected to grow ... 2022 at a CAGR of 7.1% therein. --> global ... value of US$6.1 bn to US$11.3 bn by 2022 at a ... announced the release of a new market research study, detailing the ... Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
Breaking Medicine Technology: